Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zkittlez is a medicinal cannabis flower product developed and produced by Valeos Pharma, a Danish medicinal cannabis company. It is an EU-GMP certified botanical product derived from the *Cannabis sativa* plant. As a whole-flower medicinal cannabis product, it contains a complex profile of cannabinoids, primarily delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), along with various terpenes. These compounds interact with the human endocannabinoid system, specifically targeting CB1 and CB2 receptors to provide therapeutic effects such as analgesia, anti-inflammatory properties, and muscle relaxation. It is intended for use in patients where medicinal cannabis is indicated under local regulations, such as for the management of chronic pain or spasticity associated with multiple sclerosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zkittlez.